ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.760
+0.030 (1.73%)
Nov 21, 2024, 4:00 PM EST - Market closed
ESSA Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Market Capitalization | 78 | 136 | 80 | 352 | 200 | 70 | |
| Market Cap Growth | 96.01% | 69.89% | -77.20% | 75.80% | 186.07% | 303.65% | |
| Enterprise Value | -54 | -16 | -94 | 150 | 164 | 69 | |
| Last Close Price | 1.73 | 3.09 | 1.82 | 8.00 | 6.90 | 3.37 | |
| PB Ratio | 0.60 | 0.94 | 0.48 | 1.81 | 2.53 | 1.43 | |
| P/TBV Ratio | 1.81 | 0.94 | 0.48 | 1.81 | 2.53 | 1.43 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | |
| Quick Ratio | 36.61 | 42.41 | 72.39 | 49.73 | 65.35 | 9.63 | |
| Current Ratio | 36.95 | 42.57 | 73.17 | 50.28 | 66.73 | 9.74 | |
| Return on Equity (ROE) | -19.83% | -17.00% | -19.44% | -26.94% | -36.57% | -43.89% | |
| Return on Assets (ROA) | -14.79% | -12.61% | -12.57% | -16.66% | -21.75% | -21.52% | |
| Return on Capital (ROIC) | -15.15% | -12.83% | -12.77% | -16.97% | -22.27% | -22.28% | |
| Earnings Yield | -36.05% | -19.51% | -43.76% | -10.46% | -11.71% | -18.23% | |
| FCF Yield | -31.06% | -14.52% | -34.91% | -7.22% | -8.48% | -17.51% | |
| Buyback Yield / Dilution | -0.28% | -0.12% | -14.44% | -71.45% | -166.13% | -84.68% | |
| Total Shareholder Return | -0.28% | -0.12% | -14.44% | -71.45% | -166.13% | -84.68% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.